Immunology

  1. Virus Induced Lymphocytes (VIL) as a novel viral antigen-specific T cell therapy for COVID-19 and potential future pandemics

    1. Rohan Sivapalan
    2. Jinyan Liu
    3. Krishnendu Chakraborty
    4. Elisa Arthofer
    5. Modassir Choudhry
    6. Philip S. Barie
    7. Dan H. Barouch
    8. Tom Henley

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Baricitinib treatment resolves lower airway inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques

    1. Timothy N. Hoang
    2. Maria Pino
    3. Arun K. Boddapati
    4. Elise G. Viox
    5. Carly E. Starke
    6. Amit A. Upadhyay
    7. Sanjeev Gumber
    8. Kathleen Busman-Sahay
    9. Zachary Strongin
    10. Justin L. Harper
    11. Gregory K. Tharp
    12. Kathryn L. Pellegrini
    13. Shannon Kirejczyk
    14. Keivan Zandi
    15. Sijia Tao
    16. Tristan R. Horton
    17. Elizabeth N. Beagle
    18. Ernestine A. Mahar
    19. Michelle YH Lee
    20. Joyce Cohen
    21. Sherrie M. Jean
    22. Jennifer S. Wood
    23. Fawn Connor-Stroud
    24. Rachelle L. Stammen
    25. Olivia M. Delmas
    26. Shelly Wang
    27. Kimberly A. Cooney
    28. Michael N. Sayegh
    29. Lanfang Wang
    30. Daniela Weiskopf
    31. Peter D. Filev
    32. Jesse Waggoner
    33. Anne Piantadosi
    34. Sudhir P. Kasturi
    35. Hilmi Al- Shakhshir
    36. Susan P. Ribeiro
    37. Rafick P. Sekaly
    38. Rebecca D. Levit
    39. Jacob D. Estes
    40. Thomas H. Vanderford
    41. Raymond F. Schinazi
    42. Steven E. Bosinger
    43. Mirko Paiardini

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Pre-clinical studies of a recombinant adenoviral mucosal vaccine to prevent SARS-CoV-2 infection

    1. Anne C. Moore
    2. Emery G. Dora
    3. Nadine Peinovich
    4. Kiersten P. Tucker
    5. Karen Lin
    6. Mario Cortese
    7. Sean N. Tucker

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protection

    1. Emma S. Winkler
    2. Pavlo Gilchuk
    3. Jinsheng Yu
    4. Adam L. Bailey
    5. Rita E. Chen
    6. Seth J. Zost
    7. Hyesun Jang
    8. Ying Huang
    9. James D. Allen
    10. James Brett Case
    11. Rachel E. Sutton
    12. Robert H. Carnahan
    13. Tamarand L. Darling
    14. Adrianus C. M. Boon
    15. Matthias Mack
    16. Richard D. Head
    17. Ted M. Ross
    18. James E. Crowe
    19. Michael S. Diamond

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates

    1. Dapeng Li
    2. Robert J Edwards
    3. Kartik Manne
    4. David R. Martinez
    5. Alexandra Schäfer
    6. S. Munir Alam
    7. Kevin Wiehe
    8. Xiaozhi Lu
    9. Robert Parks
    10. Laura L. Sutherland
    11. Thomas H. Oguin
    12. Charlene McDanal
    13. Lautaro G. Perez
    14. Katayoun Mansouri
    15. Sophie M. C. Gobeil
    16. Katarzyna Janowska
    17. Victoria Stalls
    18. Megan Kopp
    19. Fangping Cai
    20. Esther Lee
    21. Andrew Foulger
    22. Giovanna E. Hernandez
    23. Aja Sanzone
    24. Kedamawit Tilahun
    25. Chuancang Jiang
    26. Longping V. Tse
    27. Kevin W. Bock
    28. Mahnaz Minai
    29. Bianca M. Nagata
    30. Kenneth Cronin
    31. Victoria Gee-Lai
    32. Margaret Deyton
    33. Maggie Barr
    34. Tarra Von Holle
    35. Andrew N. Macintyre
    36. Erica Stover
    37. Jared Feldman
    38. Blake M. Hauser
    39. Timothy M. Caradonna
    40. Trevor D. Scobey
    41. Wes Rountree
    42. Yunfei Wang
    43. M. Anthony Moody
    44. Derek W. Cain
    45. C. Todd DeMarco
    46. ThomasN. Denny
    47. Christopher W. Woods
    48. Elizabeth W. Petzold
    49. Aaron G. Schmidt
    50. I-Ting Teng
    51. Tongqing Zhou
    52. Peter D. Kwong
    53. John R. Mascola
    54. Barney S. Graham
    55. Ian N. Moore
    56. Robert Seder
    57. Hanne Andersen
    58. Mark G. Lewis
    59. David C. Montefiori
    60. Gregory D. Sempowski
    61. Ralph S. Baric
    62. Priyamvada Acharya
    63. Barton F. Haynes
    64. Kevin O. Saunders

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Ubiquitin ligase RIPLET mediates polyubiquitination of RIG-I and LGP2 and regulates the innate immune responses to SARS-CoV-2 infection

    1. Takahisa Kouwaki
    2. Tasuku Nishimura
    3. Guanming Wang
    4. Reiko Nakagawa
    5. Hiroyuki Oshiumi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. SARS-CoV-2 RBD219-N1C1: A Yeast-Expressed SARS-CoV-2 Recombinant Receptor-Binding Domain Candidate Vaccine Stimulates Virus Neutralizing Antibodies and T-cell Immunity in Mice

    1. Jeroen Pollet
    2. Wen-Hsiang Chen
    3. Leroy Versteeg
    4. Brian Keegan
    5. Bin Zhan
    6. Junfei Wei
    7. Zhuyun Liu
    8. Jungsoon Lee
    9. Rahki Kundu
    10. Rakesh Adhikari
    11. Cristina Poveda
    12. Maria Jose Villar
    13. Ana Carolina de Araujo Leao
    14. Joanne Altieri Rivera
    15. Zoha Momin
    16. Portia M. Gillespie
    17. Jason T. Kimata
    18. Ulrich Strych
    19. Peter J. Hotez
    20. Maria Elena Bottazzi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. SARS-CoV-2 infection suppresses ACE2 function and antiviral immune response in the upper respiratory tract of infected patients

    1. Lucía Gutiérrez-Chamorro
    2. Eva Riveira-Muñoz
    3. Clara Barrios
    4. Vanesa Palau
    5. Marta Massanella
    6. Edurne Garcia-Vidal
    7. Roger Badia
    8. Sònia Pedreño
    9. Jordi Senserrich
    10. Eva Rodríguez
    11. Bonaventura Clotet
    12. Cecilia Cabrera
    13. Oriol Mitjà
    14. Marta Crespo
    15. Julio Pascual
    16. Marta Riera
    17. Ester Ballana

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. SARS-CoV-2 infection severity is linked to superior humoral immunity against the spike

    1. Jenna J. Guthmiller
    2. Olivia Stovicek
    3. Jiaolong Wang
    4. Siriruk Changrob
    5. Lei Li
    6. Peter Halfmann
    7. Nai-Ying Zheng
    8. Henry Utset
    9. Christopher T. Stamper
    10. Haley L. Dugan
    11. William D. Miller
    12. Min Huang
    13. Ya-Nan Dai
    14. Christopher A. Nelson
    15. Paige D. Hall
    16. Maud Jansen
    17. Kumaran Shanmugarajah
    18. Jessica S. Donington
    19. Florian Krammer
    20. Daved H. Fremont
    21. Andrzej Joachimiak
    22. Yoshihiro Kawaoka
    23. Vera Tesic
    24. Maria Lucia Madariaga
    25. Patrick C. Wilson

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2

    1. Alexandra C. Walls
    2. Brooke Fiala
    3. Alexandra Schäfer
    4. Samuel Wrenn
    5. Minh N. Pham
    6. Michael Murphy
    7. Longping V. Tse
    8. Laila Shehata
    9. Megan A. O’Connor
    10. Chengbo Chen
    11. Mary Jane Navarro
    12. Marcos C. Miranda
    13. Deleah Pettie
    14. Rashmi Ravichandran
    15. John C. Kraft
    16. Cassandra Ogohara
    17. Anne Palser
    18. Sara Chalk
    19. E-Chiang Lee
    20. Kathryn Guerriero
    21. Elizabeth Kepl
    22. Cameron M. Chow
    23. Claire Sydeman
    24. Edgar A. Hodge
    25. Brieann Brown
    26. Jim T. Fuller
    27. Kenneth H. Dinnon
    28. Lisa E. Gralinski
    29. Sarah R. Leist
    30. Kendra L. Gully
    31. Thomas B. Lewis
    32. Miklos Guttman
    33. Helen Y. Chu
    34. Kelly K. Lee
    35. Deborah H. Fuller
    36. Ralph S. Baric
    37. Paul Kellam
    38. Lauren Carter
    39. Marion Pepper
    40. Timothy P. Sheahan
    41. David Veesler
    42. Neil P. King

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity
Previous Page 128 of 174 Next